{"date":"2025-12-23","count":23,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-7829-2025-12-23-2119-6mh3w9","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"21:19:44","subject":"公告本公司董事會決議增資子公司案","clause":"第17款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-12-23 21:19，「公告本公司董事會決議增資子公司案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-12-23-1856-5lrh5b","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"18:56:28","subject":"公告本公司董事會通過解除經理人競業禁止之限制案","clause":"第21款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-12-23 18:56，「公告本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1783-2025-12-23-1854-194nj2c","company_id":"1783","company":"和康生","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"18:54:49","subject":"公告本公司因會計師事務所內部調整自2026年第一季起更換會計師","clause":"第7款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：和康生（1783），2025-12-23 18:54，「公告本公司因會計師事務所內部調整自2026年第一季起更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-12-23-1842-5lrh5b","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"18:42:29","subject":"公告本公司董事會通過解除經理人競業禁止之限制案","clause":"第22款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-12-23 18:42，「公告本公司董事會通過解除經理人競業禁止之限制案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-12-23-1841-i8tame","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"18:41:12","subject":"公告本公司董事會通過總經理任命案","clause":"第6款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-12-23 18:41，「公告本公司董事會通過總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-12-23-1839-t37szc","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"18:39:30","subject":"公告本公司因會計師事務所內部調整自2026年第二季起更換會計師","clause":"第7款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-12-23 18:39，「公告本公司因會計師事務所內部調整自2026年第二季起更換會計師」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-12-23-1828-ygkpln","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"18:28:01","subject":"公告本公司董事會通過副總經理任命案","clause":"第8款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-12-23 18:28，「公告本公司董事會通過副總經理任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6547-2025-12-23-1827-ag0ktz","company_id":"6547","company":"高端疫苗","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"18:27:29","subject":"本公司受邀參加永豐金證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-24","cite_as":"公開資訊觀測站重大訊息：高端疫苗（6547），2025-12-23 18:27，「本公司受邀參加永豐金證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-12-23-1827-1s7xzm3","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"18:27:19","subject":"公告本公司向關係人取得使用權資產","clause":"第20款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-12-23 18:27，「公告本公司向關係人取得使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-12-23-1818-rkjq39","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"18:18:37","subject":"本公司對子公司豪潔實業股份有限公司資金貸與案","clause":"第23款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-12-23 18:18，「本公司對子公司豪潔實業股份有限公司資金貸與案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4148-2025-12-23-1812-n30hzw","company_id":"4148","company":"全宇生技-KY","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"18:12:23","subject":"公告本公司召開法人說明會","clause":"第12款","fact_date":"2025-12-29","cite_as":"公開資訊觀測站重大訊息：全宇生技-KY（4148），2025-12-23 18:12，「公告本公司召開法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-12-23-1749-ck22v9","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"17:49:11","subject":"代子公司「中國化學製藥股份有限公司」董事會通過對財團法人王民寧先生紀念基金會捐贈案","clause":"第43款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-12-23 17:49，「代子公司「中國化學製藥股份有限公司」董事會通過對財團法人王民寧先生紀念基金會捐贈案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-12-23-1748-cg5wtq","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"17:48:50","subject":"公告本公司受邀參加富邦證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-12-24","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-12-23 17:48，「公告本公司受邀參加富邦證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3716-2025-12-23-1748-12kb9nt","company_id":"3716","company":"中化控股","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"17:48:23","subject":"公告本公司董事會決議將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」","clause":"第6款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：中化控股（3716），2025-12-23 17:48，「公告本公司董事會決議將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6496-2025-12-23-1737-6suliq","company_id":"6496","company":"科懋","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"17:37:21","subject":"代子公司科進製藥科技股份有限公司公告董事會決議通過變更營業地址","clause":"第53款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：科懋（6496），2025-12-23 17:37，「代子公司科進製藥科技股份有限公司公告董事會決議通過變更營業地址」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4117-2025-12-23-1655-12jx2ya","company_id":"4117","company":"普生","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"16:55:41","subject":"代重要子公司居禮股份有限公司公告會計主管異動","clause":"第11款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：普生（4117），2025-12-23 16:55，「代重要子公司居禮股份有限公司公告會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-12-23-1611-1vkske3","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"16:11:30","subject":"本公司受邀參加元富證券舉辦之生技產業法人說明會","clause":"第12款","fact_date":"2026-01-07","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-12-23 16:11，「本公司受邀參加元富證券舉辦之生技產業法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-12-23-1536-ozqyjx","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"15:36:47","subject":"本公司受邀參加國票綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-26","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-12-23 15:36，「本公司受邀參加國票綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1734-2025-12-23-1532-ozqyjx","company_id":"1734","company":"杏輝","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"15:32:17","subject":"本公司受邀參加國票綜合證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-26","cite_as":"公開資訊觀測站重大訊息：杏輝（1734），2025-12-23 15:32，「本公司受邀參加國票綜合證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3205-2025-12-23-1514-194aq5z","company_id":"3205","company":"佰研","market":"上櫃","industry":"生技醫療","date":"2025-12-23","time":"15:14:11","subject":"本公司受邀參加福邦證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-12-24","cite_as":"公開資訊觀測站重大訊息：佰研（3205），2025-12-23 15:14，「本公司受邀參加福邦證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7829-2025-12-23-1513-10keza6","company_id":"7829","company":"思捷優達-KY","market":"興櫃","industry":"生技醫療","date":"2025-12-23","time":"15:13:24","subject":"本公司代子公司思捷優達股份有限公司公告開發中新藥YA-101獲日本厚生勞動省孤兒藥資格認定。","clause":"第44款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：思捷優達-KY（7829），2025-12-23 15:13，「本公司代子公司思捷優達股份有限公司公告開發中新藥YA-101獲日本厚生勞動省孤兒藥資格認定。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1762-2025-12-23-1433-12kb9nt","company_id":"1762","company":"中化生","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"14:33:30","subject":"公告本公司董事會決議將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」","clause":"第6款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：中化生（1762），2025-12-23 14:33，「公告本公司董事會決議將「薪資報酬委員會」更名為「薪資報酬暨提名委員會」」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4142-2025-12-23-1425-l7qirp","company_id":"4142","company":"國光生","market":"上市","industry":"生技醫療","date":"2025-12-23","time":"14:25:14","subject":"公告本公司會計主管異動","clause":"第8款","fact_date":"2025-12-23","cite_as":"公開資訊觀測站重大訊息：國光生（4142），2025-12-23 14:25，「公告本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}